Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Franklin Financial Services
FRAF
$280M
| $1.34M | ﹤0.01% |
44,408
+153
| +0.3% | +$4.65K |
|
3252
Purple Innovation
PRPL
$41.7M
| $1.33M | ﹤0.01% |
53,843
+641
| +1% | +$18.5K |
|
3253
RCM Technologies
RCMT
$208M
| $1.32M | ﹤0.01% |
65,126
-12,383
| -16% | -$239K |
|
3254
Seres Therapeutics
MCRB
$48.9M
| $1.31M | ﹤0.01% |
69,432
+12,751
| +22% | +$259K |
|
|
AUGX
3255
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.31M | ﹤0.01% |
556,611
+58,175
| +12% | +$117K |
|
3256
Veritone
VERI
$122M
| $1.31M | ﹤0.01% |
363,659
-6,166
| -2% | -$18.8K |
|
3257
LiveWire
LVWR
$221M
| $1.31M | ﹤0.01% |
213,968
-783
| -0.4% | -$5.35K |
|
|
SACH
3258
Sachem Capital Corp
SACH
$39.8M
| $1.3M | ﹤0.01% |
516,918
+33,317
| +7% | +$84.1K |
|
|
SWKH
3259
DELISTED
SWK Holdings
SWKH
| $1.3M | ﹤0.01% |
95,036
-9,421
| -9% | -$128K |
|
|
TE
3260
T1 Energy
TE
$1.63B
| $1.3M | ﹤0.01% |
1,342,028
+2,162
| +0.2% | +$2.95K |
|
3261
Waldencast
WALD
$178M
| $1.3M | ﹤0.01% |
357,478
+2,778
| +0.8% | +$9.37K |
|
3262
eHealth
EHTH
$43.9M
| $1.3M | ﹤0.01% |
318,292
+935
| +0.3% | +$4.04K |
|
3263
Canadian Solar
CSIQ
$1.08B
| $1.3M | ﹤0.01% |
77,300
-6,514
| -8% | -$95.2K |
|
3264
Actinium Pharmaceuticals
ATNM
$25M
| $1.29M | ﹤0.01% |
686,153
+19,843
| +3% | +$78.4K |
|
3265
Indivior Pharmaceuticals
INDV
$4.58B
| $1.29M | ﹤0.01% |
132,239
+9,500
| +8% | +$111K |
|
3266
DiaMedica Therapeutics
DMAC
$364M
| $1.29M | ﹤0.01% |
306,958
+70,070
| +30% | +$259K |
|
3267
VEON
VEON
$3.95B
| $1.28M | ﹤0.01% |
42,068
-1,496
| -3% | -$41.2K |
|
|
SFBC
3268
Sound Financial Bancorp
SFBC
$111M
| $1.28M | ﹤0.01% |
23,885
+1,407
| +6% | +$69.1K |
|
3269
TransAlta
TAC
$3.93B
| $1.28M | ﹤0.01% |
122,621
+2,524
| +2% | +$21K |
|
3270
ALX Oncology
ALXO
$290M
| $1.28M | ﹤0.01% |
700,847
+441
| +0.1% | +$1.64K |
|
3271
American Outdoor Brands
AOUT
$157M
| $1.28M | ﹤0.01% |
138,336
+6,092
| +5% | +$54.2K |
|
|
MRDN
3272
Meridian Holdings Inc
MRDN
$182M
| $1.27M | ﹤0.01% |
45,423
+2,682
| +6% | +$77K |
|
|
UBFO
3273
DELISTED
United Security Bancshares
UBFO
| $1.27M | ﹤0.01% |
145,776
+14,668
| +11% | +$116K |
|
3274
Fractyl Health
GUTS
$111M
| $1.27M | ﹤0.01% |
501,476
+313,335
| +167% | +$1.02M |
|
|
ASRT
3275
DELISTED
Assertio
ASRT
| $1.27M | ﹤0.01% |
71,657
+2,850
| +4% | +$56.5K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.